http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101302378-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2511-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-67 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43563 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00 |
filingDate | 2011-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101302378-B1 |
titleOfInvention | Ceatacin gene derived from Pabam moth larva and its use |
abstract | The present invention provides an antimicrobial-related seatacin (Seattacin) protein derived from Spodoptera exigua larvae, a gene encoding the protein, a recombinant vector comprising the gene, a host cell transformed with the recombinant vector, and the recombinant vector. The present invention relates to a mass production method of a ceatacin protein, a method for mass production of an antimicrobial composition comprising the protein as an active ingredient, and an antibody against the protein, the method comprising transforming a host cell to overexpress the ceatacin gene. |
priorityDate | 2011-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 175.